American College of Rheumatology Annual Meeting

Healio brings you the highlights from the American College of Rheumatology Annual Meeting. Refer back to this page often for the latest news from ACR, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Obesity ‘significantly’ increases risk for RA in women

December 20, 2018
Abdominal obesity heightens the risk for rheumatoid arthritis considerably among women aged 55 years and older regardless of BMI, according to…
Meeting News

Phase 3 data support etanercept monotherapy for PsA

December 13, 2018
CHICAGO — Phase 3 data from the SEAM-PsA study presented at the ACR/ARHP 2018 Annual Meeting showed that etanercept alone or in combination…
Meeting News

AS linked to increased risk for certain cancer types

December 12, 2018
CHICAGO — Patients with ankylosing spondylitis had an increased risk for melanoma, hematological malignancies, kidney and thyroid cancer but a…
Meeting News

Greater hip abductor strength improves long-term function in knee OA

December 11, 2018
CHICAGO — Greater hip abductor strength reduced the 5-year risk for poor functional outcomes and the 2-year risk for tibiofemoral cartilage…
Meeting News

Tofacitinib does not confer meaningful increase in risk for venous thromboembolism

December 10, 2018
CHICAGO – Treatment with tofacitinib results in a numerically higher, but not statistically significant, risk for venous thromboembolism versus…
Meeting News

High BMD independently associated with knee, hip OA

December 7, 2018
CHICAGO — High estimated bone mineral density of the heel and femoral bone density were associated with an increased risk for osteoarthritis of…
Meeting News

Knowledge, attitudes about prescription NSAID use for OA varies by ethnicity

November 29, 2018
CHICAGO — Hispanic patients with osteoarthritis were less likely than non-Hispanic white patients to believe that prescription NSAIDs could…
Meeting News

COAST-W: Ixekizumab effective in hard-to-treat AS patients

November 28, 2018
CHICAGO — Ixekizumab significantly improved the signs and symptoms of ankylosing spondylitis in patients who previously did not respond to or…
Meeting News

Bimekizumab improves outcomes among PsA patients

November 27, 2018
CHICAGO — Bimekizumab, a monoclonal antibody that neutralizes both IL-17A and IL-17F, significantly improved both musculoskeletal and skin…
Meeting News

Tanezumab safe, effective against OA

November 26, 2018
CHICAGO — A recent study showed that tanezumab was well-tolerated and superior to placebo in patients with osteoarthritis. This analysis is…